Spikevax XBB.1.5 0.1 mg/mL dispersion for injection
Spikevax XBB.1.5 50 micrograms dispersion for injection
Spikevax XBB.1.5 50 micrograms dispersion for injection in pre-filled syringe
Spikevax XBB.1.5 is indicated for active immunisation to prevent COVID‑19 caused by SARS-CoV-2 in individuals 6 months of age and older.
Patient Information Leaflet
Summary of Product Characteristics
Spikevax bivalent Original/Omicron BA.4-5 (50 micrograms/50 micrograms)/mL dispersion for injection
Spikevax bivalent Original/Omicron BA.4-5 25 micrograms/25 micrograms dispersion for injection
Spikevax bivalent Original/Omicron BA.4-5 25 micrograms/25 micrograms dispersion for injection in pre-filled syringe
Spikevax bivalent Original/Omicron BA.4-5 is indicated for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 6 months of age and older.
Patient Information Leaflet
Summary of Product Characteristics
Spikevax bivalent Original/Omicron BA.1 (50 micrograms/50 micrograms)/mL dispersion for injection
Spikevax bivalent Original/Omicron BA.1 25 micrograms/25 micrograms dispersion for injection
Spikevax bivalent Original/Omicron BA.1 25 micrograms/25 micrograms dispersion for injection in pre-filled syringe
Spikevax bivalent Original/Omicron BA.1 is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against COVID-19.
Patient Information Leaflet
Summary of Product Characteristics
Direct Healthcare Professional Communication
Spikevax (previously COVID‑19 Vaccine Moderna)
Spikevax is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 6 months of age and older.
Patient Information Leaflet
Summary Product Characteristics
Tools
Temperature Excursion Tool
See what to do with vials of the Moderna COVID-19 Vaccine that may have experienced a temperature excursion prior to administering.
Contact Moderna
8am-5pm CET – Mon - Fri
EMEAMedinfo@modernatx.com